Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
First-line PARP inhibition in ovarian cancer — standard of care for all?
Susana N. Banerjee & Christopher J. Lord
Links
DOI
PubMed
Journal
Nature Reviews Clinical Oncology
Authors
Susana N. Banerjee
,
Christopher J. Lord
Funding
Cancer Research UK Grant 14276
Cancer Research UK Grant 24439